HomeCompareOIBRQ vs MRK

OIBRQ vs MRK: Dividend Comparison 2026

OIBRQ yields 14304.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OIBRQ wins by $6.200647691763291e+34M in total portfolio value
10 years
OIBRQ
OIBRQ
● Live price
14304.00%
Share price
$0.00
Annual div
$0.09
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.200647691763291e+34M
Annual income
$62,005,644,173,574,930,000,000,000,000,000,000,000,000.00
Full OIBRQ calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — OIBRQ vs MRK

📍 OIBRQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOIBRQMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OIBRQ + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OIBRQ pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OIBRQ
Annual income on $10K today (after 15% tax)
$1,215,840.00/yr
After 10yr DRIP, annual income (after tax)
$52,704,797,547,538,690,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, OIBRQ beats the other by $52,704,797,547,538,690,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OIBRQ + MRK for your $10,000?

OIBRQ: 50%MRK: 50%
100% MRK50/50100% OIBRQ
Portfolio after 10yr
$3.1003238458816457e+34M
Annual income
$31,002,822,086,787,466,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OIBRQ
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-4.1
Piotroski
2/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OIBRQ buys
0
MRK buys
0
No recent congressional trades found for OIBRQ or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOIBRQMRK
Forward yield14304.00%2.76%
Annual dividend / share$0.09$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$6.200647691763291e+34M$56.8K
Annual income after 10y$62,005,644,173,574,930,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$6.200642243777155e+34M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: OIBRQ vs MRK ($10,000, DRIP)

YearOIBRQ PortfolioOIBRQ Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$2,871,500$2,860,800.00$11,206$366.19+$2.86MOIBRQ
2$1,538,546,748$1,535,474,242.99$12,650$502.35+$1538.53MOIBRQ
3$1,539,413,573,748$1,537,767,328,727.98$14,407$694.19+$1539413.56MOIBRQ
4$2,877,598,042,349,199$2,875,950,869,825,287.50$16,585$967.82+$2877598042.33MOIBRQ
5$10,051,608,218,885,784,000$10,048,529,188,980,470,000.00$19,342$1,363.89+$10051608218885.77MOIBRQ
6$65,618,353,516,193,770,000,000$65,607,598,295,399,556,000,000.00$22,913$1,947.19+$65618353516193768.00MOIBRQ
7$800,623,293,842,664,100,000,000,000$800,553,082,204,401,800,000,000,000.00$27,662$2,823.89+$800623293842664062976.00MOIBRQ
8$18,258,269,866,020,430,000,000,000,000,000$18,257,413,199,096,020,000,000,000,000,000.00$34,159$4,173.35+$1.825826986602043e+25MOIBRQ
9$778,265,474,753,531,100,000,000,000,000,000,000$778,245,938,404,774,600,000,000,000,000,000,000.00$43,337$6,308.80+$7.782654747535311e+29MOIBRQ
10$62,006,476,917,632,920,000,000,000,000,000,000,000,000$62,005,644,173,574,930,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$6.200647691763291e+34MOIBRQ

OIBRQ vs MRK: Complete Analysis 2026

OIBRQStock

Oi S.A., a switched fixed-line telephony services concessionaire, provides telecommunication services in Brazil. The company offers fixed telephony services, including voice, data communication, and pay TV services; local and intraregional long-distance carrier services; domestic and international long-distance services; mobile telecommunications and corporate solutions; and maintenance, and repair services. It also provides call center and telemarketing, Internet, network, and Wi-Fi Internet services; and financial, and payment and credit system services. In addition, the company engages in the investment management activities, as well as raising funds in the international market. It serves residential, subscription and prepaid, mobile broadband, small, medium-sized, and large corporate customers. The company was formerly known as Brasil Telecom S.A. and changed its name to Oi S.A. in February 2012. Oi S.A. was founded in 1998 and is headquartered in Rio de Janeiro, Brazil. On June 20, 2016, Oi S.A. along with its subsidiaries filed for bankruptcy protection.

Full OIBRQ Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this OIBRQ vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OIBRQ vs SCHDOIBRQ vs JEPIOIBRQ vs OOIBRQ vs KOOIBRQ vs MAINOIBRQ vs JNJOIBRQ vs ABBVOIBRQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.